| Ridgeline Services Consulting Services | |
|
2162 Childress Road Alum Creek WV 25003 | |
| (304) 745-7837 | |
| (360) 242-5842 |
| Full Name | Ridgeline Services Consulting Services |
|---|---|
| Speciality | Family Medicine |
| Location | 2162 Childress Road, Alum Creek, West Virginia |
| Authorized Official Name and Position | Gregory Zornes (PRESIDENT/OWNER) |
| Authorized Official Contact | 3046872445 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ridgeline Services Consulting Services Po Box 184 Alum Creek WV 25003-0184 Ph: (304) 745-7837 | Ridgeline Services Consulting Services 2162 Childress Road Alum Creek WV 25003 Ph: (304) 745-7837 |
| NPI Number | 1992337869 |
|---|---|
| Provider Enumeration Date | 02/10/2020 |
| Last Update Date | 06/08/2021 |
| Certification Date | 06/08/2021 |
| Medicare PECOS PAC ID | 1850792896 |
|---|---|
| Medicare Enrollment ID | O20210628002097 |
News Archive
A new study describes how immunocompromised vaccine recipients may not always respond as expected to the COVID-19 vaccine.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992337869 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Secondary |
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Richard W Knapp |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1134407018 PECOS PAC ID: 3870732530 Enrollment ID: I20130610000763 |
News Archive
A new study describes how immunocompromised vaccine recipients may not always respond as expected to the COVID-19 vaccine.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
› Verified 8 days ago
| Provider Name | James Mosley |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1154484202 PECOS PAC ID: 3779956016 Enrollment ID: I20240125003806 |
News Archive
A new study describes how immunocompromised vaccine recipients may not always respond as expected to the COVID-19 vaccine.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
› Verified 8 days ago
| Provider Name | Beverly Dawn Mcdonald |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1124638994 PECOS PAC ID: 5092188342 Enrollment ID: I20240126000300 |
News Archive
A new study describes how immunocompromised vaccine recipients may not always respond as expected to the COVID-19 vaccine.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
› Verified 8 days ago
News Archive
A new study describes how immunocompromised vaccine recipients may not always respond as expected to the COVID-19 vaccine.
Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, today announced it has entered into a collaboration with Bayer HealthCare (Bayer) for the development and commercialization of a novel gene therapy for the treatment of hemophilia A.
The Institute of Biomedical Engineering and Technology (BMET) will be officially opened this evening at the University of Sydney, and will significantly advance this highly multidisciplinary research for life sciences and medicine.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
› Verified 8 days ago
Seasons Treatment, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2162 Childress Rd, Alum Creek, WV 25003 Phone: 304-745-7837 Fax: 360-242-5842 |